India's life-sciences patent guidelines promise clarity, but consistency will be the test
By Freny Patel ( September 18, 2026, 02:43 GMT | Comment) -- India's draft life-sciences patent guidelines could improve predictability without easing patentability standards, but their impact will depend on consistent examination and applying existing jurisprudence to emerging pharmaceutical and biotechnology inventions.India's proposed pharmaceutical and biotechnology patent guidelines could make one of the world's more demanding life-sciences patent regimes easier to navigate without making it more permissive, but their publication shouldn't be mistaken for reform....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.